Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Novel von willebrand factor targeting thrombolytic TGD001 is effective in diverse thrombotic models, demonstrating its potential as a universal thrombolytic

Volker Laux, Claudia Tersteeg, Sarah Vandelanotte, Sarah Mc Fie, Danielle Versluis, Filio Petsini, Anne-Sophie Delmote, Kristof Vercruysse, Simon de Meyer, Karen Vanhoorelbeke, Steven de Maat

Blood (2025) 146 (Supplement 1): 203.

https://doi.org/10.1182/blood-2025-203

Published: 2025

Journal Articles

Protein expression profiling suggests relevance of noncanonical pathways in isolated pulmonary embolism

Blood (2021) 137 (19): 2681–2693.

https://doi.org/10.1182/blood.2019004571

Published: 2021

Includes: Supplemental data

Journal Articles

Plasma Kallikrein Contributes to Ellagic Acid-Induced Coagulation in the Absence of FXI By Activating Factor IX

Mayken Visser, Rene van Oerle, Hugo ten Cate, MD PhD, Volker Laux, PhD, Stefan Heitmeier, PhD, Henri M.H. Spronk, PhD

Blood (2019) 134 (Supplement_1): 1106.

https://doi.org/10.1182/blood-2019-131738

Published: 2019

Journal Articles

Acute Efficacy of a Novel Anti-Tissue Factor Pathway Inhibitor Antibody BAY 1093884 in Hemophilia A Mouse Severe Tail Bleeding

Yifan Xu, Maria Koellenberger, Volker Laux, Katalin Kauser, Derek Sim, PhD

Blood (2015) 126 (23): 3500.

https://doi.org/10.1182/blood.V126.23.3500.3500

Published: 2015

Journal Articles

Glycopegylated Factor IX Enables Prolonged Efficacy After Subcutaneous Injection But Requires a Higher Than Expected Plasma Activity To Prevent Bleeding In Hemophilia B Mice

Derek S Sim, Alan Brooks, Cornell Mallari, Yifan Xu, Rick I Feldman, Doug Schneider, Chandra Patel, Eric Blasko, Elena Ho, Yan Su, Bing Liu, Volker Laux, John E Murphy

Blood (2013) 122 (21): 1104.

https://doi.org/10.1182/blood.V122.21.1104.1104

Published: 2013

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

Novel von willebrand factor targeting thrombolytic TGD001 is effective in diverse thrombotic models, demonstrating its potential as a universal thrombolytic

Protein expression profiling suggests relevance of noncanonical pathways in isolated pulmonary embolism

Plasma Kallikrein Contributes to Ellagic Acid-Induced Coagulation in the Absence of FXI By Activating Factor IX

Acute Efficacy of a Novel Anti-Tissue Factor Pathway Inhibitor Antibody BAY 1093884 in Hemophilia A Mouse Severe Tail Bleeding

Glycopegylated Factor IX Enables Prolonged Efficacy After Subcutaneous Injection But Requires a Higher Than Expected Plasma Activity To Prevent Bleeding In Hemophilia B Mice

Email alerts

ASH Publications

American Society of Hematology

Update search

Novel von willebrand factor targeting thrombolytic TGD001 is effective in diverse thrombotic models, demonstrating its potential as a universal thrombolytic

Protein expression profiling suggests relevance of noncanonical pathways in isolated pulmonary embolism

Plasma Kallikrein Contributes to Ellagic Acid-Induced Coagulation in the Absence of FXI By Activating Factor IX

Acute Efficacy of a Novel Anti-Tissue Factor Pathway Inhibitor Antibody BAY 1093884 in Hemophilia A Mouse Severe Tail Bleeding

Glycopegylated Factor IX Enables Prolonged Efficacy After Subcutaneous Injection But Requires a Higher Than Expected Plasma Activity To Prevent Bleeding In Hemophilia B Mice

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only